EVP, Chief Medical Officer of Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Shah Jatin, sells 1,186 shares worth $17,590
According to Karyopharm Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 22 08:12 PM, company EVP, Chief Medical Officer, Shah Jatin disclosed selling 1,186 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $17,590 in total. As of Feb 18, Shah Jatin now owns 51,791 shares in total worth about $772,721.72.
For the last few recent trades made by Karyopharm Therapeutics Inc. (NASDAQ:KPTI) EVP, Chief Medical Officer, Shah Jatin, we have the following information:
- SEC Form 4 filing: Feb 11: Sold 1,748 shares at the rate of $15.52 per share. Total worth of this trade was $27,127. Total number of shares owned as of Feb 11 were 48,127
- SEC Form 4 filing: Jul 15: Sold 589 shares at the rate of $19.46 per share. Total worth of this trade was $11,462. Total number of shares owned as of Jul 15 were 43,229
- SEC Form 4 filing: Feb 19: Sold 1,375 shares at the rate of $16.48 per share. Total worth of this trade was $22,663. Total number of shares owned as of Feb 19 were 40,759
Posted by
George Daniels
on Tuesday February 23 2021, 12:03 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
